Page 2174 - Williams Hematology ( PDFDrive )

2148 Part XII: Hemostasis and Thrombosis Chapter 124: Inherited Deficiencies of Coagulation Factors II, V, V+VIII, VII, X, XI, and XIII 2149

227. Gailani D, Broze GJ Jr: Factor XI activation in a revised model of blood coagulation. 258. Salomon O, Zivelin A, Livnat T, et al: Prevalence, causes, and characterization of factor
Science 253:909, 1991. XI inhibitors in patients with inherited factor XI deficiency. Blood 101:4783, 2003.
228. Naito K, Fujikawa K: Activation of human blood coagulation factor XI independent of 259. Zucker M, Zivelin A, Teitel J, Seligsohn U: Induction of an inhibitor antibody to factor
factor XII: Factor XI is activated by thrombin and factor XIa in the presence of nega- XI in a patient with severe inherited factor XI deficiency by Rh immune globulin. Blood
tively charged surfaces. J Biol Chem 266:7353, 1991. 111:1306, 2008.
229. Baglia FA, Shrimpton CN, Lopez JA, Walsh PN: The glycoprotein Ib-IX-V complex 260. Stern DM, Nossel HL, Owen J: Acquired antibody to factor XI in a patient with congen-
mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem ital factor XI deficiency. J Clin Invest 69:1270, 1982.
278:21744, 2003. 261. Connelly NR, Brull SJ: Anesthetic management of a patient with factor XI deficiency
230. Von dem Borne PA, Meijers JC, Bouma BN: Effect of heparin on the activation of factor and factor XI inhibitor undergoing a cesarean section. Anesth Analg 76:1365, 1993.
XI by fibrin-bound thrombin. Thromb Haemost 76:347, 1996. 262. Livnat T, Zivelin A, Martinowitz U, et al: Prerequisites for recombinant factor VIIa-
231. Osterud B, Bouma BN, Griffin JH: Human blood coagulation factor IX: Purification, induced thrombin generation in plasmas deficient in factors VIII, IX or XI. J Thromb
properties, and mechanism of activation by activated factor XI. J Biol Chem 253:5946, Haemost 4:192, 2006.
1978. 263. Duckert F, Jung E, Sherling DH: An undescribed congenital haemorrhagic diathesis
232. Bouma BN, Meijers JC: Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 5:179,
procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). J Thromb 1960.
Haemost 1:1566, 2003. 264. Ivaskevicius V, Seitz R, Kohler HP et al: International registry on factor XIII deficiency:
233. Bajzar L, Morser J, Nesheim M: TAFI, or plasma procarboxypeptidase B, couples the A basis formed mostly on European data. Thromb Haemost 97:914, 2007.
coagulation and fibrinolytic cascades through the thrombin-thrombomodulin com- 265. Muszbek L, Adany R, Mikkola H: Novel aspects of blood coagulation factor XIII: I.
plex. J Biol Chem 271:16603, 1996. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 33:357, 1996.
234. Broze GJ Jr, Higuchi DA: Coagulation-dependent inhibition of fibrinolysis: Role of 266. Schwartz ML, Pizzo SV, Hill RL, McKee PA: Human factor XIII from plasma and plate-
carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood lets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of
88:3815, 1996. fibrinogen and fibrin. J Biol Chem 248:1395, 1973.
235. Asakai R, Davie EW, Chung DW: Organization of the gene for human factor XI. 267. Muszbek L, Ariens RA, Ichinose A, ISTH SSC Subcommittee On Factor X: Factor XIII:
Biochemistry 26:7221, 1987. Recommended terms and abbreviations. J Thromb Haemost 5:181, 2007.
236. Kato A, Asakai R, Davie EW, Aoki N: Factor XI gene (F11) is located on the distal end 268. Weiss MS, Metzner HJ, Hilgenfeld R: Two nonproline cis peptide bonds may be impor-
of the long arm of human chromosome 4. Cytogenet Cell Genet 52:77, 1989. tant for factor XIII function. FEBS Lett 423:291, 1998.
237. Asakai R, Chung DW, Ratnoff OD, Davie EW: Factor XI (plasma thromboplastin 269. Yee VC, Pedersen LC, Le Trong I, et al: Three-dimensional structure of a transglutami-
antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from nase: Human blood coagulation factor XIII. Proc Natl Acad Sci U S A 91:7296, 1994.
three types of point mutations. Proc Natl Acad Sci U S A 86:7667, 1989. 270. Lorand L, Graham RM: Transglutaminases: Crosslinking enzymes with pleiotropic
238. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, et al: Inheritance and bleeding in functions. Nat Rev Mol Cell Biol 4:140, 2003.
factor XI deficiency. Br J Haematol 69:521, 1988. 271. Yee VC, Le Trong I, Bishop PD, et al: Structure and function studies of factor XIIIa by
239. Zadra G, Asselta R, Tenchini ML, et al: Simultaneous genotyping of coagulation factor X-ray crystallography. Semin Thromb Hemost 22:377, 1996.
XI type II and type III mutations by multiplex real-time polymerase chain reaction to 272. Gentile V, Saydak M, Chiocca EA, et al: Isolation and characterization of cDNA clones
determine their prevalence in healthy and factor XI-deficient Italians. Haematologica to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem
93:715, 2008. 266:478, 1991.
240. Zivelin A, Bauduer F, Ducout L, et al: Factor XI deficiency in French Basques is caused 273. Phillips MA, Stewart BE, Qin Q, et al: Primary structure of keratinocyte transglutami-
predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 99:2448, nase. Proc Natl Acad Sci U S A 87:9333, 1990.
2002. 274. Sung LA, Chien S, Chang LS, et al: Molecular cloning of human protein 4.2: A major
241. Girolami A, Scarparo P, Bonamigo E, et al: A cluster of factor XI-deficient patients due component of the erythrocyte membrane. Proc Natl Acad Sci U S A 87:955, 1990.
to a new mutation (Ile 436 Lys) in northeastern Italy. Eur J Haematol 88:229, 2012. 275. Ichinose A, McMullen BA, Fujikawa K, Davie EW: Amino acid sequence of the b sub-
242. Kim J, Song J, Lyu CJ, et al: Population-specific spectrum of the F11 mutations in unit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry
Koreans: Evidence for a founder effect. Clin Genet 82:180, 2012. 25:4633, 1986.
243. Kravtsov DV, Wu W, Meijers JC, et al: Dominant factor XI deficiency caused by muta- 276. Souri M, Kaetsu H, Ichinose A: Sushi domains in the B subunit of factor XIII responsi-
tions in the factor XI catalytic domain. Blood 104:128, 2004. ble for oligomer assembly. Biochemistry 47:8656, 2008.
244. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG: Definition of the bleed- 277. Lorand L, Gray AJ, Brown K, et al: Dissociation of the subunit structure of fibrin stabi-
ing tendency in factor XI-deficient kindreds: A clinical and laboratory study. Thromb lizing factor during activation of the zymogen. Biochem Biophys Res Commun 56:914,
Haemost 73:194, 1995. 1974.
245. Salomon O, Steinberg DM, Seligsohn U: Variable bleeding manifestations characterize 278. Mary A, Achyuthan KE, Greenberg CS: B-chains prevent the proteolytic inactivation of
different types of surgery in patients with severe factor XI deficiency enabling parsimo- the a-chains of plasma factor XIII. Biochim Biophys Acta 966:328, 1988.
nious use of replacement therapy. Haemophilia 12:490, 2006. 279. Biswas A, Ivaskevicius V, Thomas A, Oldenburg J: Coagulation factor XIII deficiency.
246. Sidi A, Seligsohn U, Jonas P, Many M: Factor XI deficiency: Detection and management Hamostaseologie 34:160, 2014.
during urological surgery. J Urol 119:528, 1978. 280. Komaromi I, Bagoly Z, Muszbek L: Factor XIII: Novel structural and functional aspects.
247. Brenner B, Laor A, Lupo H, et al: Bleeding predictors in factor-XI deficient patients. J Thromb Haemost 9:9, 2011.
Blood Coagul Fibrinolysis 8:511, 1997. 281. Kohler HP: Interaction between FXIII and fibrinogen. Blood 121:1934, 2013.
248. Bolton-Maggs PH, Peretz H, Butler R, et al: A common ancestral mutation (C128X) 282. Smith KA, Adamson PJ, Pease RJ et al: Interactions between factor XIII and the alpha C
occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb region of fibrinogen. Blood 2011; 117: 3460–3468.
Haemost 2:918, 2004. 283. Ariens RA, Lai TS, Weisel JW, et al: Role of factor XIII in fibrin clot formation and
249. Brodsky JB, Burgess GE III: Pulmonary embolism with factor XI deficiency. JAMA effects of genetic polymorphisms. Blood 100:743, 2002.
234:1156, 1975. 284. Varadi A, Scheraga HA: Localization of segments essential for polymerization and
250. Evans G, Pasi KJ, Mehta A, et al: Recurrent venous thromboembolic disease and factor for calcium binding in the gamma-chain of human fibrinogen. Biochemistry 25:519,
XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic 1986.
leukaemia, factor V Leiden and heterozygous plasminogen deficiency. Blood Coagul 285. Smith KA, Adamson PJ, Pease RJ et al: Interactions between factor XIII and the alpha C
Fibrinolysis 8:437, 1997. region of fibrinogen. Blood 117:3460, 2011.
251. Salomon O, Steinberg DM, Koren-Morag N, et al: Reduced incidence of ischemic stroke 286. Smith KA, Pease RJ, Avery CA et al: The activation peptide cleft exposed by thrombin
in patients with severe factor XI deficiency. Blood 111:4113, 2008. cleavage of FXIII-A(2) contains a recognition site for the fibrinogen alpha chain. Blood
252. Luo D, Szaba FM, Kummer LW, et al: Factor XI deficient mice display reduced inflam- 121:2117, 2013.
mation, coagulopathy, and bacterial growth during listeriosis. Infect Immun 80:91, 287. Doolittle RF, Hong S, Wilcox D: Evolution of the fibrinogen gamma’ chain: Implications
2012. for the binding of factor XIII, thrombin and platelets. J Thromb Haemost 7:1431, 2009.
253. Gailani D, Lasky NM, Broze GJ Jr: A murine model of factor XI deficiency. Blood 288. Sakata Y, Aoki N: Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing
Coagul Fibrinolysis 8:134, 1997. factor. J Clin Invest 65:290, 1980.
254. James P, Salomon O, Mikovic D, Peyvandi F: Rare bleeding disorders-bleeding assessment 289. Mosher DF, Schad PE, Vann JM: Cross-linking of collagen and fibronectin by factor XIIIa:
tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia Localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J
20(Suppl 4):71, 2014. Biol Chem 255:1181, 1980.
255. Mannucci PM, Bauer KA, Santagostino E, et al: Activation of the coagulation 290. Fraser SR, Booth NA, Mutch NJ: The antifibrinolytic function of factor XIII is exclu-
cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood sively expressed through alpha(2)-antiplasmin cross-linking. Blood 117:6371, 2011.
84:1314, 1994. 291. Van Giezen JJ, Minkema J, Bouma BN, Jansen JW: Cross-linking of alpha 2-antiplasmin
256. O’Connell NM, Riddell AF, Pascoe G, et al: Recombinant factor VIIa to prevent surgical to fibrin is a key factor in regulating blood clot lysis: Species differences. Blood Coagul
bleeding in factor XI deficiency. Haemophilia 14:775, 2008. Fibrinolysis 4:869, 1993.
257. Schulman S, Németh: An illustrative case and a review on the dosing of recombinant 292. Richardson VR, Cordell P, Standeven KF, Carter AM: Substrates of factor XIII-A: Roles
factor VIIa in congenital factor XI deficiency. Haemophilia 12:223, 2006. in thrombosis and wound healing. Clin Sci (Lond) 124:123, 2013.

Kaushansky_chapter 124_p2133-2150.indd 2149 17/09/15 3:43 pm